Pulmonary hypertension in chronic respiratory and cardiac diseases;Hypertension pulmonaire des maladies respiratoires et cardiaques chroniques

Revue du Praticien

Volumn 58, Issue 18, 2008, Pages 2019-2023

  Cordier, Jean François ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; DISEASE SEVERITY; FIBROSING ALVEOLITIS; HEART CATHETERIZATION; HEART DISEASE; HUMAN; HYPOXIA; PULMONARY HYPERTENSION; REVIEW;

CHRONIC DISEASE; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES;

EID: 57749182217     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. White PD. Heart disease. New York: Mac Millan Company; 1931.
2. Han MK, McLaughlin VV, Criner GJ, Martinez FJ. Pulmonary diseases and the heart. Circulation 2007;116:2992-3005.
3. Chaouat A, Canuet M, Gomez E, Chabot F, Weitzenblum E. Hypertension pulmonaire des affections respiratoires chroniques. Rev Mal Respir 2007;24:509-21.
4. Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172: 189-94.
5. Eddahibi S, Chaouat A, Morrell N, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003;108:1839-44.
6. Nathan SD. Pulmonary hypertension in interstitial lung disease. Int J Clin Pract 2008;160: 21-8.
7. Nathan SD, Noble PW, Tuder RM. Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 2007;175:875-80.
8. Fell CD, Martinez FJ. The impact of pulmonary arterial hypertension on idiopathic pulmonary fibrosis. Chest 2007;131:641-3.
9. Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007;132:998-1006.
10. Cordier JF. Fibrose pulmonaire idiopathique. Rev Prat 2007;57: 2227-42.
11. Handa T, Nagai S, Miki S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006;129: 1246-52.
12. Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005;25:783-8.
13. Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006;61:68-74.
14. Dauriat G, Mal H, Thabut G, et al. Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis. Transplantation 2006;81:746-50.
15. Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000;161:216-23.
16. Dalen JE, Matloff JM, Evans GL, et al. Early reduction of pulmonary vascular resistance after mitral-valve replacement. N Engl J Med 1967;277:387-94.
17. Braunwald E, Braunwald NS, Ross J Jr, Morrow AG. Effects of mitral-valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension. N Engl J Med 1965;273:509-14.
18. Zagol BW, Wodi LA, Davis RC, Newman KP. A hyperactive pulmonary vasculature in response to chronic mitral regurgitation. Am J Med Sci 2007;333:390-3.
19. Forfia PR. Approach to patients with heart failure and pulmonary hypertension. Curr Treat Options Cardiovasc Med 2007;9:302-9.
20. Oudiz RJ. Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med 2007;28:233-41.
21. Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. J Thorac Cardiovasc Surg 1991;101:432-44.
22. Murali S, Kormos RL, Uretsky BF, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 1993;126:896-904.
23. Delgado JF, Conde E, Sanchez V, et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail 2005;7:1011-6.
24. Klotz S, Deng MC, Hanafy D, et al. Reversible pulmonary hypertension in heart transplant candidates-pretransplant evaluation and outcome after orthotopic heart transplantation. Eur J Heart Fail 2003;5:645-53.
25. Braun S, Schrotter H, Schmeisser A, Strasser RH. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. Int J Cardiol 2007;115:67-72.
26. Jabbour A, Keogh A, Hayward C, Macdonald P. Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation. Eur J Heart Fail 2007;9:674-7.